GSK’s $3B Takeover Of Human Genome Survives 2 Early Suits – site.law360.com

Law360, New York (July 26, 2012, 6:13 PM ET) -- Human Genome Sciences Inc. on Thursday beat back two shareholder challenges to its $3 billion takeover by GlaxoSmithKline PLC, securing rejections of motions seeking to delay the close of the tender offer ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>